Skip to main content
. Author manuscript; available in PMC: 2023 Aug 7.
Published in final edited form as: Neuromuscul Disord. 2022 Feb 26;32(4):347–357. doi: 10.1016/j.nmd.2022.02.011

Table 1. Human and Mouse Muscle Velocity Recovery Cycle Measurements (MVRCs) compared using parameters described for human MVRCs.

Excitability Measures Mean ± SE (n) P for Welch rank test (non parametric)
Human TA Mouse TA Human Vs Mouse
MRRP 3.70 ± 0.12 (26) 4.79 ± 0.23 (67) p=0.00128*
ESN (%) 11.19 ± 0.44 (26) 3.33 ± 0.29 (67) p=9.21×10-21*
ESN@(ms) 7.98 ± 0.23 (26) 10.78 ± 0.36 (67) p=7.08×10-9*
SNEnd (ms) 745.3 ± 39.5 (26) 53.55 ± 5.12(66) p=6.97×10-23*
5ESN (%) 13.01 ± 0.54 (26) 4.90 ± 0.51 (62) p=1.21×10-15*
LSN (%) 3.68 ± 0.17 (26) 0.013 ± 0.066 (70) p=2.61×10-24*
2XLSN (%) 2.25 ± 0.15 (26) -0.323 ± 0.075 (70) p=3.12-×1023*
5XLSN (%) 7.03 ± 0.31 (26) -0.83 ± 0.15 (70) p=2.62×10-24*
RSN (%) 0.125 ± 0.037 (26) -0.248 ± 0.044 (68) p=8.90×10-9*
5XRSN (%) 0.986 ± 0.081 (26) -0.568 ± 0.068 (68) p=1.15×10-21*

TA, Tibialis Anterior; MRRP, muscle relative refractory period; ESN, early supernormality (up to 15 ms); ESN@, interstimulus interval for maximum ESN; SNEnd, time supernormal period to 1 conditioning stimulus ends, 5ESN, early supernormality after 5 conditioning stimuli; LSN, late supernormality (50–150 ms); 2XLSN extra supernormality after 2 conditioning stimuli compared with 1 conditioning stimulus; 5XLSN, extra supernormality after 5 conditioning stimuli compared with 1 conditioning stimulus; RSN, residual supernormality (900–1000 ms); 5XRSN, extra residual supernormality after 5 conditioning stimuli.

*

p<0.01